Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 38, 2003 - Issue 10
Submit an article Journal homepage
52
Views
12
CrossRef citations to date
0
Altmetric
Article

Complement activation in plasma before and after Infliximab treatment in Crohn disease

E. Zimmermann‐Nielsen Dept. of Surgery K, Hospital of Funen, Svendborg Sygehus, Svendborg, DenmarkCorrespondenceerzn.shf‐post1@fyns‐amt.dk
,
J. Agnholt Dept. of Medicine V, Aarhus University Hospital, Aarhus, Denmark
,
O. Thorlacius‐Ussing Dept. of Surgical Gastroenterology A, Aalborg Hospital, Aalborg, Denmark
,
J. F. Dahlerup Dept. of Surgery A, Odense University Hospital, Odense, Denmark
&
G. Baatrup Dept. of Surgery K, Hospital of Funen, Svendborg Sygehus, Svendborg, Denmark
Pages 1050-1054 | Received 27 Nov 2002, Accepted 04 Aug 2003, Published online: 08 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Brian W Behm & Stephen J Bickston. (2006) Medical management of Crohn's disease: current therapy and recent advances. Expert Review of Clinical Immunology 2:1, pages 109-120.
Read now

Articles from other publishers (11)

Ingrid Hokstad, Gia Deyab, Morten Wang Fagerland, Torstein Lyberg, Gunnbjørg Hjeltnes, Øystein Førre, Stefan Agewall, Tom Eirik Mollnes & Ivana Hollan. (2019) Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study. PLOS ONE 14:7, pages e0220079.
Crossref
E Nissilä, K Korpela, A I Lokki, R Paakkanen, S Jokiranta, W M de Vos, M-L Lokki, K-L Kolho & S Meri. (2017) C4B gene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease . Clinical and Experimental Immunology 190:3, pages 394-405.
Crossref
Umang Jain, Anthony R. Otley, Johan Van Limbergen & Andrew W. Stadnyk. (2014) The Complement System in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 20:9, pages 1628-1637.
Crossref
C. Piras, A. Soggiu, V. Greco, A. Cassinotti, G. Maconi, S. Ardizzone, A. Amoresano, G. Bianchi Porro, L. Bonizzi & P. Roncada. (2014) Serum protein profiling of early and advanced stage Crohn's disease. EuPA Open Proteomics 3, pages 48-59.
Crossref
Sachiko Nakajima, Hideki Iijima, Shinichiro Shinzaki, Satoshi Egawa, Takahiro Inoue, Akira Mukai, Yoshito Hayashi, Jumpei Kondo, Tomofumi Akasaka, Tsutomu Nishida, Tatsuya Kanto, Eiichi Morii, Tsunekazu Mizushima, Eiji Miyoshi, Masahiko Tsujii & Norio Hayashi. (2011) Functional analysis of agalactosyl IgG in inflammatory bowel disease patients. Inflammatory Bowel Diseases 17:4, pages 927-936.
Crossref
Christina Hoffmann, Peter Hoffmann, Andreas Lun, Carsten Büning, Falk Hiepe, Hans U. Scherer, Elisabeth Steinhagen-Thiessen & Andreas Weimann. (2010) Is there a role for mannan-binding lectin in the diagnosis of inflammatory bowel disease?. Immunogenetics 62:4, pages 231-235.
Crossref
Kristen O. Arseneau, Hiroshi Tamagawa, Theresa T. Pizarro & Fabio Cominelli. (2007) Innate and adaptive immune responses related to IBD pathogenesis. Current Gastroenterology Reports 9:6, pages 508-512.
Crossref
Brian W. Behm & Stephen J. Bickston. (2007) Efficacy of infliximab for luminal and fistulizing Crohn’s disease and in ulcerative colitis. Current Treatment Options in Gastroenterology 10:3, pages 171-177.
Crossref
Sarah A De La Rue & Stephen J Bickston. (2006) Evidence-based medications for the treatment of the inflammatory bowel diseases. Current Opinion in Gastroenterology 22:4, pages 365-369.
Crossref
Erik Zimmermann-Nielsen, Henning Grønbæk, Jens Frederik Dahlerup, Gunnar Baatrup & Ole Thorlacius-Ussing. (2005) Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. BMC Gastroenterology 5:1.
Crossref
S. KatohH. KitazawaT. ShimosatoM. TohnoY. KawaiT. Saito. (2004) Cloning and Characterization of Swine Interleukin-17, Preferentially Expressed in the Intestines. Journal of Interferon & Cytokine Research 24:9, pages 553-559.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.